Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Macaluso

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|July 5, 2016
Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitisS Renna, E Orlando, F S Macaluso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2021
Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseasesM Maida, G C Morreale, S Sferrazza, et al.
Journal of Clinical Medicine|April 13, 2024
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD SurveyMarta Vernero, Cristina Bezzio, Davide G Ribaldone, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2015
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis CS Petta, E Vanni, E Bugianesi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 18, 2021
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseasesAnna Viola, Marco Muscianisi, Fabio S Macaluso, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trialA Orlando, F Mocciaro, M Ventimiglia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 7, 2025
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)D Noviello, W Fries, A Orlando, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|July 5, 2016
Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitisS Renna, E Orlando, F S Macaluso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2021
Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseasesM Maida, G C Morreale, S Sferrazza, et al.
Journal of Clinical Medicine|April 13, 2024
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD SurveyMarta Vernero, Cristina Bezzio, Davide G Ribaldone, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2015
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis CS Petta, E Vanni, E Bugianesi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 18, 2021
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseasesAnna Viola, Marco Muscianisi, Fabio S Macaluso, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trialA Orlando, F Mocciaro, M Ventimiglia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 7, 2025
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)D Noviello, W Fries, A Orlando, et al.
Pageof 4